First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) shares shot up 2% during mid-day trading on Thursday . The company traded as high as $160.29 and last traded at $159.62. 15,846 shares traded hands during trading, a decline of 40% from the average session volume of 26,419 shares. The stock had previously closed at $156.53.
First Trust NYSE Arca Biotechnology Index Fund Stock Up 2.0 %
The firm’s fifty day simple moving average is $152.25 and its 200-day simple moving average is $151.74. The company has a market cap of $1.21 billion, a PE ratio of 17.20 and a beta of 0.86.
Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund
A number of large investors have recently bought and sold shares of the stock. Independence Bank of Kentucky acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the first quarter valued at approximately $31,000. Principal Securities Inc. acquired a new position in First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter valued at $32,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 14.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 932 shares of the company’s stock worth $148,000 after purchasing an additional 118 shares during the period. Main Street Financial Solutions LLC acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth $201,000. Finally, Jones Financial Companies Lllp acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth $201,000.
First Trust NYSE Arca Biotechnology Index Fund Company Profile
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
See Also
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- When to Sell a Stock for Profit or Loss
- Sales Breakout Sends This Semiconductor Stock to Record High
- What Does Downgrade Mean in Investing?
- Surprise Buying Opportunity on This Dividend Aristocrat
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
